The 3 analysts offering 1 year price forecasts for CTNM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to CTNM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CTNM EPS for the last quarter is −3.55 USD despite the estimation of −1.12 USD. In the next quarter EPS is expected to reach −0.35 USD. Track more of Contineum Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, CTNM price target is 28.00 USD with a max estimate of 30.00 USD and a min estimate of 25.00 USD. Check if this forecast comes true in a year, meanwhile watch Contineum Therapeutics, Inc. stock price chart and keep track of the current situation with CTNM news and stock market news.